Amylyx Pharmaceuticals, Inc. (AMLX) Net margin 2021–2024
Amylyx Pharmaceuticals, Inc. (AMLX) net profit margin by fiscal year — reported net income divided by reported revenue.
-345.4%FY2024 · since FY2021: -30853.0% → -345.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -345.4% | -358.3 pp |
| FY2023 | 12.9% | +905.3 pp |
| FY2022 | -892.4% | +29960.6 pp |
| FY2021 | -30853.0% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice